DrugPatentWatch Database Preview
Anchen Pharms Company Profile
» See Plans and Pricing
What is the competitive landscape for ANCHEN PHARMS, and what generic and branded alternatives to ANCHEN PHARMS drugs are available?
ANCHEN PHARMS has twenty-six approved drugs.
There are two tentative approvals on ANCHEN PHARMS drugs.
Summary for Anchen Pharms
| US Patents: | 0 |
| Tradenames: | 22 |
| Ingredients: | 22 |
| NDAs: | 26 |
Drugs and US Patents for Anchen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anchen Pharms | CLONIDINE HYDROCHLORIDE | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 202983-002 | Apr 2, 2014 | DISCN | No | No | Start Trial | Start Trial | |||||
| Anchen Pharms | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 201573-001 | Jul 18, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Anchen Pharms | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 205784-004 | Jun 9, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Anchen Pharms | TRETINOIN | tretinoin | CAPSULE;ORAL | 201687-001 | Oct 24, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
